🇺🇸 FDA
Pipeline program

glatiramer acetate

PM016

Approved small_molecule active

Quick answer

glatiramer acetate for Multiple Sclerosis is a Approved program (small_molecule) at TEVA PHARMACEUTICAL INDUSTRIES LTD with 2 ClinicalTrials.gov record(s).

Program details

Company
TEVA PHARMACEUTICAL INDUSTRIES LTD
Indication
Multiple Sclerosis
Phase
Approved
Modality
small_molecule
Status
active

Clinical trials